Browsing Barts Cancer Institute by Subject "3 Good Health and Well Being"
Now showing items 1-4 of 4
-
Abstract P6-10-05: Mutations in the RNA Splicing Factor SF3B1 drive endocrine therapy resistance and confer a targetable replication stress response defect through PARP inhibition
(American Association for Cancer Research (AACR), 2023-03-01) -
DNA alterations in papillary renal cancer.
(American Society of Clinical Oncology (ASCO), 2023-02-20)